Clinical Trial Update: Psilocybin for Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

Phase 3 trial update for psilocybin in major depressive disorder. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Usona Institute | Conditions: Depressive Disorder, Major | Phase 3 | Status: ACTIVE_NOT_RECRUITING